Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study

Annals of Medicine

Volumn 47, Issue 1, 2015, Pages 40-46

  Suomela, Emmi ^a   Oikonen, Mervi ^a   Virtanen, Johanna ^b   Parkkola, Riitta ^b   Jokinen, Eero ^c   Laitinen, Tomi ^d   Hutri Kähönen, Nina ^e   Kähönen, Mika ^f   Lehtimäki, Terho ^e   Taittonen, Leena ^g,h   Tossavainen, Päivi ^h   Jula, Antti ⁱ   Loo, Britt Marie ⁱ   Mikkilä, Vera ^a,c   Younossi, Zobair ^j   Viikari, Jorma S A ^b   Juonala, Markus ^b   Raitakari, Olli T ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^f TAMPERE UNIVERSITY HOSPITAL   (Finland)

^g VAASA CENTRAL HOSPITAL   (Finland)

^h UNIVERSITY OF OULU   (Finland)

ⁱ NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^j INOVA FAIRFAX HOSPITAL   (United States)

more..

Author keywords

Cohort studies; Epidemiologic factors; Fatty liver; Normal body weight; Overweight; Prevalence

Indexed keywords

ALANINE AMINOTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PROTEIN; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; ECHOGRAPHY; FATTY LIVER; FEMALE; FOLLOW UP; HUMAN; INSULIN BLOOD LEVEL; LIVER EXAMINATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PHYSICAL ACTIVITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; YOUNG ADULT; BLOOD; BLOOD PRESSURE; COHORT ANALYSIS; COMPLICATION; DIET RESTRICTION; DRINKING BEHAVIOR; FINLAND; MOTOR ACTIVITY; PREVALENCE; RISK FACTOR; SEX DIFFERENCE;

ADULT; ALANINE TRANSAMINASE; ALCOHOL DRINKING; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; COHORT STUDIES; FASTING; FATTY LIVER; FEMALE; FINLAND; HUMANS; INSULIN; MALE; MIDDLE AGED; MOTOR ACTIVITY; OVERWEIGHT; PREVALENCE; RISK FACTORS; SEX FACTORS; SMOKING; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84923289255     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2014.966752     Document Type: Article

References (50)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346: 1221-31
2. Reue K. A thematic review series: lipid droplet storage and metabolism: from yeast to man. J Lipid Res. 2011; 52: 1865-8
3. Quiroga AD, Lehner R. Liver triacylglycerol lipases. Biochim Biophys Acta. 2012;1821:762-9
4. Bhatia LS, Curzen NP, Calder PC, Byrne 4. CD. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?. Eur Heart J. 2012;33:1190-200
5. T argher G, Day C P, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010; 363: 1341-50
6. Li X, Xia M, Ma H, Hofman A, Hu Y, Yan H, et al. Liver fat content is associated with increased carotid atherosclerosis in a Chinese middleaged and elderly population: the Shanghai Changfeng study. Atherosclerosis. 2012; 224: 480-5
7. Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore). 2012;91:319-27
8. Pisto P, Santaniemi M, Bloigu R, Ukkola O, Kes ä niemi YA. Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. BMJ Open. 2014; 4: e004973
9. Raitakari OT, Juonala M, R ö nnemaa T, Keltikangas-J ä rvinen L, R ä s änen L, Pietik äinen M, et al. Cohort profile: the cardiovascular risk in Young Finns Study. Int J Epidemiol. 2008; 37: 1220-6
10. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-5
11. Männistö S, Virtanen M, Mikkonen T, Pietinen P. Reproducibility and validity of a food frequency questionnaire in a case-control study on breast cancer. J Clin Epidemiol. 1996; 49: 401-9
12. Telama R, Yang X, Viikari J, V ä lim ä ki I, Wanne O, Raitakari O. Physical activity from childhood to adulthood: a 21-year tracking study. Am J Prev Med. 2005; 28: 267-73
13. The National Public Health Institute, Nutrition Unit. F ineli. Finnish Food Composition Database. Release 7. Helsinki, Finland. 2007. Available at: http://www.fi neli.fi (accessed 2 November 2013
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-19
16. Edens MA, van Ooijen PM, Post WJ, Haagmans MJ, Kristanto W, Sijens PE, et al. Ultrasonography to quantify hepatic fat content: validation by 1H magnetic resonance spectroscopy. Obesity (Silver Spring). 2009;17:2239-44
17. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fi brosis and steatosis. Br Med J (Clin Res Ed). 1986;292:13-15
18. Juonala M, Viikari JS, K ä h ö nen M, Laitinen T, Taittonen L, Loo BM, et al. Alcohol consumption is directly associated with carotid intimamedia thickness in Finnish young adults: the Cardiovascular Risk in Young Finns Study. Atherosclerosis. 2009; 204: e93-8
19. Riquelme A, Arrese M, Soza A, Morales A, Baudrand R, Perez-Ayuso RM, et al. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int. 2009;29:82-8
20. Left on HB, Rosa A, Cohen M. Diagnosis and epidemiology of cirrhosis. Med Clin North Am. 2009; 93: 787-99, vii
21. B ellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut. 1997;41:845-50
22. Lu XL, Luo JY, Tao M, Gen Y, Zhao P, Zhao HL, et al. Risk factors for alcoholic liver disease in China. World J Gastroenterol. 2004; 10: 2423-6
23. Koskinen J, Magnussen CG, K ä h ö nen M, Loo BM, Marniemi J, Jula A, et al. Association of liver enzymes with metabolic syndrome and carotid atherosclerosis in young adults. The Cardiovascular Risk in Young Finns Study. Ann Med. 2012; 44: 187-95
24. Lavoie J M, Gauthier MS. R egulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise. Cell Mol Life Sci. 2006; 63: 1393-409
25. Shah K, Stuffl ebam A, Hilton TN, Sinacore DR, Klein S, Villareal DT. Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. Obesity (Silver Spring). 2009;17:2162-8
26. Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R, et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut. 2011;60:1278-83
27. Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. P revalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int. 2006;26:856-63
28. Park SH, Kim BI, Yun JW, Kim JW, Park DI, Cho YK, et al. Insulin resistance and C-reactive protein as independent risk factors for nonalcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol. 2004; 19: 694-8
29. Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, Johansson LM, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology. 2009;137:865-72
30. Otgonsuren M, Stepanova M, Gerber L, Younossi ZM. Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease. Dig Dis Sci. 2013; 58: 1132-40
31. Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and signifi cant liver disease. Hepatology. 2010;51:1593-602
32. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011; 34: 274-85
33. Vasunta RL, Kes ä niemi YA, Ylitalo AS, Ukkola OH. High ambulatory blood pressurEvalues associated with non-alcoholic fatty liver in middle- aged adults. J Hypertens. 2012;30:2015-19
34. Lau K, Lorbeer R, Haring R, Schmidt CO, Wallaschofski H, Nauck M, et al. The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study. J Hypertens. 2010;28:1829-35
35. Hu X, Huang Y, Bao Z, Wang Y, Shi D, Liu F, et al. Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units. BMC Gastroenterol. 2012; 12: 123
36. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-95
37. Lopez-Suarez A, Guerrero JM, Elvira-Gonzalez J, Beltran-Robles M, Canas-Hormigo F, Bascunana-Quirell A. Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase. Eur J Gastroenterol Hepatol. 2011;23:1011-17
38. Kotronen A, Yki-J ä rvinen H, M ä nnis 38. ö o S, Saarikoski L, Korpi-Hy ö v ä lti E, Oksa H, et al. Non-alcoholic and alcoholic fatty liver disease - two diseases of affl uence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey. BMC Public Health. 2010; 10: 237
39. Dai HF, Shen Z, Yu CH, Zhang XC, Li YM. Epidemiology of fatty liver in an islander population of China: a population-based case-control study. Hepatobiliary Pancreat Dis Int. 2008; 7: 373-8
40. Karnikowski M, Cordova C, Oliveira RJ, Karnikowski MG, Nobrega Ode T. Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults. Sao Paulo Med J. 2007; 125: 333-7
41. Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to diff erent grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract. 2009; 84: 84-91
42. Caballeria L, Pera G, Auladell MA, Toran P, Munoz L, Miranda D, et al. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. Eur J Gastroenterol Hepatol. 2010; 22: 24-32
43. Shen L, Fan JG, Shao Y, Zeng MD, Wang JR, Luo GH, et al. Prevalence of nonalcoholic fatty liver among administrative Officers in Shanghai: an epidemiological survey. World J Gastroenterol. 2003; 9: 1106-10
44. Stepanova M, Younossi ZM. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol. 2012; 10: 646-50
45. Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, Shi SL, et al. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol. 2007; 13: 6419-24
46. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000; 132: 112-17
47. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic signifi cance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol. 2006; 40: 745-52
48. Al Knawy B, Shiff man M. P ercutaneous liver biopsy in clinical practice. Liver Int. 2007;27:1166-73
49. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005; 128: 1898-906
50. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002; 123: 745-50